An excellent response to topical therapy of four congenital hemidysplasia with ichthyosiform erythroderma and limb defects syndrome patients with an increased concentration of simvastatin ointment

X. Yu,L. Chen,Z. Yang,Y. Gu,W. Zheng,Z. Wu,M. Li,Z. Yao
DOI: https://doi.org/10.1111/jdv.15838
2019-10-14
Journal of the European Academy of Dermatology and Venereology
Abstract:<p>Congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD) syndrome is a rare X‐linked dominant disorder characterized by peculiar cutaneous presentations and ipsilateral skeletal abnormalities, caused by mutations in NAD (P) H steroid dehydrogenaselike (NSDHL) gene.<sup>1</sup> Its defect leads to the deficiency of cholesterol and the accumulation of toxic metabolic intermediates resulting in the phenotype of CHILD naevus.<sup>2</sup></p><p>This article is protected by copyright. All rights reserved.</p>
dermatology
What problem does this paper attempt to address?